Perfuse Therapeutics is conducting trials for the treatment for glaucoma and diabetic retinopathy, aiming to restore vision ...

Among female collegiate athletes, mild obstructive sleep apnea (OSA) is more common than previously expected and pulse wave ...

The funding comes from MTPConnect’s Targeted Translation Research Accelerator Drugs and Devices program, backed by the ...

To better understand the health needs being addressed through online consultations, for reference, Doctor Anywhere’s 2024 data highlight the top five most in-demand specialties: dermatology, ear, nose ...

Dr. Austin recommends something she calls the “next-day rule.” That means monitoring your pain levels not only during exercise, but the rest of that day and the next. “Some people don’t tie in that, ...

Calf ache can feel like a small trouble, but it can be unexpectedly critical further, and occasionally, it’s an indicator of ...

Cardiovascular diseases are a major global health concern, causing millions of deaths annually. Recognizing early warning signs like chest pain, shortness of breath, swelling, and fatigue is crucial ...

Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

Semaglutide was associated with improved maximum walking distance across type 2 diabetes subgroups among patients with ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and ...

The global peripheral vascular devices market is set to witness a growth rate of 6% in the next 5 years. Rising prevalence of peripheral vascular diseases (PVDs); technological advancements in ...

Peripheral vascular disease (PVD), commonly referred to as peripheral arterial disease (PAD) or peripheral artery occlusive disease (PAOD), refers to the obstruction of large arteries not within ...